RespireRx Pharmaceuticals Inc (fka RSPI)

[bladerunner1717]

ombow,

Since you have written to Stoll before and gotten timely responses, you may want to ask him a few questions. One that I'm especially interested in hearing his response to is how he felt/feels about the design of the DARPA trial in sleep deprivation. If COR were to retain rights to the narcolepsy/EDS indication, how would Stoll proceed and what changes would he make in the design of the the sleep deprivation trials?

You might also ask him about the company's dwindling financial resources and how he plans to address that problem.


Bladerunner